Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Ascent Pharmaceuticals, Inc. Patents
Assignee:
Ascent Pharmaceuticals, Inc.
Address:
Billerica, MA
No. of patents:
8
Patents:












Patent Number Title Of Patent Date Issued
5684038 Composition and process for prevention and treatment of cutaneous immediate hypersensitivity rea November 4, 1997
A process and pharmaceutical composition for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amid
5684037 Composition and process for prevention and treatment of cutaneous immediate hypersensitivity rea November 4, 1997
A process and pharmaceutical composition for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amid
5672358 Controlled release aqueous emulsion September 30, 1997
A controlled release aqueous emulsion is disclosed, as are its method of manufacture and use as a vehicle for delivering medicaments in liquid form. A contemplated emulsion comprises an oil-in-water emulsion having an average oil particle size of about 100 nm to about 250 nm, a pH value
5626879 Terfenadine oral granules May 6, 1997
The present invention contemplates a dry, granular terfenadine composition. That composition comprises (i) particulate terfenadine and (ii) a polyethylene oxide-polypropylene oxide-polyethylene oxide block copolymer having an HLB number of 24 that is a wetting agent for the terfenadine
5576346 Process for treating uremic pruritus November 19, 1996
A process and pharmaceutical composition for treatment of uremic pruritus in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amide thereof: ##STR1## dissolved or disper
5552436 Process for treating hemangioma September 3, 1996
A process and pharmaceutical composition for treatment of hemangioma in humans is disclosed. The pharmaceutical composition comprises a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amide thereof: ##STR1## dissolved or dispersed in a
5532270 Composition and process for prevention and treatment of cutaneous immediate hypersensitivity rea July 2, 1996
A process and pharmaceutical composition for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amid
5455049 Terfenadine oral powder October 3, 1995
The present invention contemplates a dry, powdered terfenadine composition. That composition comprises(a) a mixture of:(i) about 1 to about 20 parts by weight micronized terfenadine and(ii) about 0.2 to about 10 parts by weight a polyethylene oxide-polypropylene oxide-polyethylene oxide bloc

 
 
  Recently Added Patents
Image decolorizing device
Controller
Real-time virtual endoscopy
Stereoscopic editing for video production, post-production and display adaptation
Providing multiple decode options for a system-on-chip (SoC) fabric
Color LED display device without color separation
Faucet handle
  Randomly Featured Patents
Data distributing method, system transmitting method, and program
Thermal isolation of electronic devices in submount used for LEDs lighting applications
Pocket insert
Apparatus for continuously fabricating cushioning laminated sheets
Direct computing experience
Stress-relieving feed
Integrated fiber optic combustion pressure sensor
Method of using invisible spacers for electro-optical display device manufacture
Sheet detecting apparatus with correction means for sheet surface condition and sheet thickness
Heat exchanger system